RPGLIFE

RPG LIFE SCIENCES

Small Cap BSE: 532983 NSE: RPGLIFE
₹727.7
-7.75 (-1.05%)
As on 30 September, 2022 | 03:00

Rpg Life Sciences Share Price

Rpg Life Sciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in RPG LIFE SCIENCES

Start SIP

Rpg Life Sciences Share Returns

  • Over 1 Month 0.94%
  • Over 3 Month 27.67%
  • Over 6 Month 29.98%
  • Over 1 Year 3.88%

Rpg Life Sciences Key Statistics

P/E Ratio 21.4
PEG Ratio 0.8
Market Cap Cr 1,204
Price to Book Ratio 4.7
EPS 30.8
Dividend 1.3
Relative Strength Index 49.14
Money Flow Index 60.48
MACD Signal 15.94
Average True Range 31.71

Rpg Life Sciences Investment Rating

  • Master Rating:
  • R P G Life Sciences has an operating revenue of Rs. 460.96 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 17% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 24% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

RPG Life Sciences Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 12910411611310893
Operating Expenses Qtr Cr 1019091878580
Operating Profit Qtr Cr 281424262313
Depreciation Qtr Cr 444444
Interest Qtr Cr 000000
Tax Qtr Cr 736762
Net Profit Qtr Cr 1881516147

Rpg Life Sciences Technicals

EMA & SMA

Current Price
727.7
-7.75 (-1.05%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 738.32
  • 50 Day
  • 699.93
  • 100 Day
  • 652.32
  • 200 Day
  • 593.49
  • 20 Day
  • 750.21
  • 50 Day
  • 699.11
  • 100 Day
  • 611.21
  • 200 Day
  • 592.69

Rpg Life Sciences Resistance and Support

PIVOT
₹732.9
Resistance
First Resistance 748.65
Second Resistance 761.85
Third Resistance 777.6
RSI 49.14
MFI 60.48
MACD Single Line 15.94
MACD 8.35
Support
First Resistance 719.7
Second Resistance 703.95
Third Resistance 690.75

Rpg Life Sciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 66,093 1,083,925 16.4
Week 54,279 1,597,986 29.44
1 Month 83,119 3,093,689 37.22
6 Month 44,358 1,676,304 37.79

Rpg Life Sciences Result Highlights

RPG Life Sciences Synopsis

NSE-Medical-Diversified

Rpg Life Sciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 440.16 Cr. and Equity Capital is Rs. 13.23 Cr. for the Year ended 31/03/2022. RPG Life Sciences Ltd. is a Public Limited Listed company incorporated on 29/03/2007 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24232MH2007PLC169354 and registration number is 169354.
Market Cap 1,204
Sales 461
Shares in Float 0.46
No of funds 9
Yield 1.32
Book Value 4.71
U/D Vol ratio 0.9
LTDebt / Equity
Alpha 0.07
Beta 0.9

RPG Life Sciences

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 72.41%72.07%72.07%
Foreign Portfolio Investors 0.15%0.12%0.2%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 20.37%20.85%20.65%
Others 7.06%6.95%7.07%

RPG Life Sciences Management

Name Designation
Mr. Harsh V Goenka Chairman
Mr. Yugal Sikri Managing Director
Mr. Rajat Bhargava Non Executive Director
Mr. Sachin Nandgaonkar Non Executive Director
Mr. Manoj K Maheshwari Independent Director
Mr. Narendra Ambwani Independent Director
Ms. Zahabiya Khorakiwala Independent Director
Mr. Bhaskar Iyer Independent Director
Dr. Lalit S Kanodia Independent Director
Mr. Mahesh S Gupta Independent Director

Rpg Life Sciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Rpg Life Sciences Corporate Action

Date Purpose Remarks
2022-08-02 Quarterly Results
2022-04-29 Audited Results
2022-01-25 Quarterly Results
2021-10-29 Quarterly Results
2021-07-28 Quarterly Results
Date Purpose Remarks
2022-07-15 FINAL Rs.9.60 per share(120%)Final Dividend
2021-08-17 FINAL Rs.7.20 per share(90%)Dividend

RPG Life Sciences MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

RPG Life Sciences FAQs

What is Share Price of RPG Life Sciences ?

RPG Life Sciences share price is ₹727 As on 30 September, 2022 | 02:46

What is the Market Cap of RPG Life Sciences ?

The Market Cap of RPG Life Sciences is ₹1203.5 Cr As on 30 September, 2022 | 02:46

What is the P/E ratio of RPG Life Sciences ?

The P/E ratio of RPG Life Sciences is 21.4 As on 30 September, 2022 | 02:46

What is the PB ratio of RPG Life Sciences ?

The PB ratio of RPG Life Sciences is 4.7 As on 30 September, 2022 | 02:46

Q1FY23